Atosiban versus betamimetics in the treatment of preterm labour in Italy: Clinical and economic importance of side-effects

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 157, Issue 2, 2011, Pages 128-135

  Wex, Jaro ^a   Abou Setta, Ahmed M ^a,b   Clerici, Graziano ^c   Di Renzo, Gian Carlo ^c  

^a Pharmarchitecture Limited   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Atosiban; Betamimetics; Economic evaluation; Preterm labour; Tocolytic

Indexed keywords

ATOSIBAN; ISOXSUPRINE; RITODRINE;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ECONOMIC ASPECT; HEADACHE; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOTENSION; ITALY; META ANALYSIS; NATIONAL HEALTH SERVICE; NAUSEA AND VOMITING; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; THORAX PAIN; TOCOLYSIS; TREMOR; VOMITING;

EID: 80955178333     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.04.009     Document Type: Review

References (54)

1. A. Nonnenmacher, H. Hopp, and J. Dudenhausen Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour Z Geburtshilfe Neonatol 213 October (5) 2009 201 206
2. M.M. Slattery, and J.J. Morrison Preterm delivery Lancet 360 November (9344) 2002 1489 1497 (Pubitemid 35356329)
3. S. Beck, D. Wojdyla, and L. Say WHO systematic review on maternal mortality and morbidity: the global burden of preterm birth Bull World Health Organ 2009
4. J.A. Martin, B.E. Hamilton, P.D. Sutton, S.J. Ventura, F. Menacker, and S. Kirmeyer Births: final data for 2004 Natl Vital Stat Rep 55 September (1) 2006 1 101
5. O. Sanu, and R.F. Lamont Critical appraisal and clinical utility of atosiban in the management of preterm labor Ther Clin Risk Manage 6 2010 191 199
6. Salute Md. Certificato di assistenza al parto (CeDAP). Analisi dell'evento nascita-Anno 2005. Quarta edizione; April 2008.
7. M. Gissler, A.D. Mohangoo, and B. Blondel Perinatal health monitoring in Europe: results from the EURO-PERISTAT project Inform Health Soc Care 35 March (2) 2010 64 79
8. M. Zimbeck, A. Mohangoo, and J. Zeitlin The European perinatal health report: delivering comparable data for examining differences in maternal and infant health Eur J Obstet Gynecol Reprod Biol 146 October (2) 2009 149 151
9. R. de Heus, E. Mulder, and G.H. Visser Management of preterm labor: atosiban or nifedipine? Int J Women Health 2 2010 137 142
10. D.L. Hoyert, T.J. Mathews, F. Menacker, D.M. Strobino, and B. Guyer Annual summary of vital statistics: 2004 Pediatrics 117 January (1) 2006 168 183 (Pubitemid 46050534)
11. S. Beck, D. Wojdyla, and L. Say The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity Bull World Health Organ 88 January (1) 2010 31 38
12. M.J. Davidoff, T. Dias, and K. Damus Changes in the gestational age distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002 Semin Perinatol 30 February (1) 2006 8 15
13. C. Stanton, J.E. Lawn, H. Rahman, K. Wilczynska-Ketende, and K. Hill Stillbirth rates: delivering estimates in 190 countries Lancet 367 May (9521) 2006 1487 1494
14. D. Roberts, and S. Dalziel Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth Cochrane Database Syst Rev 3 2006 CD004454
15. G.C. Di Renzo, and L.C. Roura Guidelines for the management of spontaneous preterm labor J Perinat Med 34 5 2006 359 366 [Review] (Pubitemid 44386155)
16. D. Papatsonis, V. Flenady, S. Cole, and H. Liley Oxytocin receptor antagonists for inhibiting preterm labour Cochrane Database Syst Rev 3 2005 CD004452
17. F. Petraglia, and G.H. Visser Prevention and management of preterm labour J Matern Fetal Neonatal Med 22 Suppl. 2 2009 24 30
18. J. Lyndrup, and R.F. Lamont The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban Expert Opin Investig Drugs 16 June (6) 2007 843 853 (Pubitemid 46887126)
19. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med. 1992;327 July (5):308-312.
20. R. Lamont, and J. van Eyck Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis Obstet Gynecol 99 March (3) 2002 518 519 author reply 9-20
21. J.A. Maloni, and E.G. Damato Reducing the risk for preterm birth: evidence and implications for neonatal nurses Adv Neonatal Care 4 June (3) 2004 166 174 (Pubitemid 38942786)
22. Panella M, Garozzo V, Librino A. Tocolisi. Moderni orientamenti. 82°Congresso Nazionale SIGO; 2006.
23. Del Savio F, Cornacchia L, Civitella C, et al. Minaccia di parto prematuro: Razionale di trattamento. 83° Congresso Nazionale SIGO; 2007.
24. Gazzetta Ufficiale della Repubblica Italiana. Modifica degli stampati e del regime di fornitura di specialita'medicinali contenenti ritodrina e isoxisuprina. Serie Generale n 166 del 19/7/2003; 2003.
25. Chan J, Cabrol D, Ingemarsson I, Marsal K, Moutquin J-M, Fisk NM. Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study. Eur J Obstet Gynecol Reprod Biol. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2006;128 (September-October (1-2)):135-141.
26. R. de Heus, B.W. Mol, and J.J. Erwich Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study BMJ 338 2009 b744
27. K. Khan, J. Zamora, and R.F. Lamont Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis J Matern Fetal Neonatal Med 23 September (9) 2010 1030 1038
28. R.F. Lamont, K.S. Khan, and B. Beattie The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review J Perinat Med 33 4 2005 287 295 (Pubitemid 41205861)
29. Rcog. Tocolytic drugs for women in preterm labour: Royal College of Obstetricians and Gynaecologists (RCOG). 2002.
30. Conoscenti G, Cal G, Zarbo R, Scollo P. Parto pretermine: presentazione delle linee guida. 85° Congresso Nazionale SIGO; 2009.
31. D. Siassakos, K. O'Brien, and T. Draycott Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour J Obstet Gynaecol 29 August (6) 2009 507 511
32. L.J. Mangham, S. Petrou, L.W. Doyle, E.S. Draper, and N. Marlow The cost of preterm birth throughout childhood in England and Wales Pediatrics 123 February (2) 2009 e312 e327
33. Institute of Medicine (US) Committee on understanding premature birth, assuring healthy outcomes R.E.B.A. Behrman Preterm birth: causes, consequences, and prevention 2007 National Academies Press (US) Washington, DC
34. J. Wex, M. Connolly, and W. Rath Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation BMC Pregnancy Childbirth 9 2009 23
35. J. Wex, H. Helmer, W. Rath, and S.K. Nielsen Economic evaluation of atosiban compared to betamimetics for the treatment of the treatment of preterm labour in Austria Value Health 12 7 2009 A294
36. P. Husslein, L. Cabero Roura, and J.W. Dudenhausen Atosiban versus usual care for the management of preterm labor J Perinat Med 35 4 2007 305 313 (Pubitemid 47036973)
37. L. Bax, L.M. Yu, N. Ikeda, H. Tsuruta, and K.G. Moons Development and validation of MIX: comprehensive free software for meta-analysis of causal research data BMC Med Res Methodol 6 2006 50
38. European Atosiban Study Group The oxytocin antagonist atosiban versus the B-agonist Terbutaline in the treatment of preterm labour. A randomised, double-blind, controlled study Acta Obstet Gynecol Scand 80 May (5) 2001 413 422
39. J.M. Moutquin, D. Sherman, and H. Cohen Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study Am J Obstet Gynecol 182 May (5) 2000 1191 1199 (Pubitemid 30353310)
40. French/Australian Atosiban Investigators Group Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol Eur J Obstet Gynecol Reprod Biol 98 February (2) 2001 177 185
41. Corosu R, Tillo R, Franceschetti S. Management del parto pretermine. 2010 [24 Novemeber 2010]; Available from: http://www.sippo.it/PDF/management-del- parto-pretermine.pdf.
42. T.M. Goodwin, G.J. Valenzuela, H. Silver, G. Creasy Atosiban Study Group Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor Obstet Gynecol 88 September (3) 1996 331 336 (Pubitemid 26293273)
43. J.Y. Shim, Y.W. Park, and B.H. Yoon Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women BJOG 113 November (11) 2006 1228 1234 (Pubitemid 44581510)
44. F.R. Cabar, R.E. Bittar, C.M. Gomes, and M. Zugaib Atosiban as a tocolytic agent: a new proposal of a therapeutic approach Rev Bras Gynecol Obstet February (30) 2 2008 87 92
45. C.H. Lin, S.Y. Lin, M.K. Shyu, S.U. Chen, and C.N. Lee Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women J Formos Med Assoc 108 June (6) 2009 493 501
46. J.F. King, V. Flenady, D. Papatsonis, G. Dekker, and B. Carbonne Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine Aust N Z J Obstet Gynaecol 43 June (3) 2003 192 198 (Pubitemid 36790188)
47. S.G. Oei, B.W. Mol, M.J. de Kleine, and H.A. Brolmann Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis Acta Obstet Gynecol Scand 78 October (9) 1999 783 788 (Pubitemid 29486053)
48. V. Tsatsaris, D. Papatsonis, F. Goffinet, G. Dekker, and B. Carbonne Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis Obstet Gynecol 97 May (5) Pt. 2 2001 840 847 (Pubitemid 32406194)
49. Y.K. Loke, and S. Derry Reporting of adverse drug reactions in randomised controlled trials - a systematic survey BMC Clin Pharmacol 1 2001 3
50. Merenda A, Stile A, Nazzaro G, De Placido G, D'Errico L, Locci M. Isossisprina cloridrato vs atosiban in pazienti affette da PROM. Nostra esperienza Atti dell'80° Congresso SIGO; 2006.
51. M. Locci, G. Nazzaro, A. Merenda, M.L. Pisaturo, P. Laviscio, and R. Poppiti Atosiban vs ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan J Obstet Gynaecol 26 July (5) 2006 396 401 (Pubitemid 44124761)
52. R. Ferriols Lisart, J. Nicolas Pico, and M. Alos Alminana Pharmacoeconomic assessment of two tocolysis protocols for the inhibition of premature delivery Farm Hosp 29 January-February (1) 2005 18 25 (Pubitemid 40478039)
53. P. Husslein, L.C. Roura, and J. Dudenhausen Clinical practice evaluation of atosiban in preterm labour management in six European countries BJOG 113 December (Suppl. 3) 2006 105 110 (Pubitemid 44934678)
54. M. Jakovljevic, M. Varjacic, and S.M. Jankovic Cost-effectiveness of ritodrine and fenoterol for treatment of preterm labor in a low-middle-income country: a case study Value Health 11 March-April (2) 2008 149 153 (Pubitemid 351473599)